Tumor-Targeting Multifunctional Nanoparticles for siRNA Delivery: Recent Advances in Cancer Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-Targeting Multifunctional Nanoparticles for siRNA Delivery: Recent Advances in Cancer Therapy

Published:2014-02-28 Issue:8 Volume:3 Page:1182-1193
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Ku Sook Hee¹,Kim Kwangmeyung¹,Choi Kuiwon¹,Kim Sun Hwa¹,Kwon Ick Chan¹²

Affiliation:

1. Center for Theragnosis, Biomedical Research Institute; Korea Institute of Science and Technology (KIST); Seoul 136-791 Republic of Korea

2. KU-KIST Graduate School of Converging Science and Technology; Korea University; Seoul 136-701 Republic of Korea

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Reference102 articles.

1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

2. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

3. Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes

4. Molecular Basis for Target RNA Recognition and Cleavage by Human RISC

5. A review of the current status of siRNA nanomedicines in the treatment of cancer

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor targeted siRNA delivery by adenosine receptor-specific curdlan nanoparticles;International Journal of Biological Macromolecules;2023-12

2. Biomaterial Based Stem Cells Therapy for Cancer;Current Stem Cell Research & Therapy;2023-11

3. Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment;Asian Journal of Pharmaceutical Sciences;2023-09

4. siRNA therapeutics: insights, challenges, remedies and future prospects;Expert Opinion on Drug Delivery;2023-08-29

5. T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems;Frontiers in Immunology;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3